Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axsome Therapeutics (AXSM) Current Taxes (2024 - 2025)

Axsome Therapeutics (AXSM) has disclosed Current Taxes for 2 consecutive years, with $101000.0 as the latest value for Q4 2025.

  • Quarterly Current Taxes fell 89.48% to $101000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $101000.0 through Dec 2025, down 89.48% year-over-year, with the annual reading at $101000.0 for FY2025, 89.48% down from the prior year.
  • Current Taxes hit $101000.0 in Q4 2025 for Axsome Therapeutics, down from $960000.0 in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $960000.0 in Q4 2024 to a low of $101000.0 in Q4 2025.